Format

Send to

Choose Destination
See comment in PubMed Commons below
Optom Vis Sci. 2010 Apr;87(4):233-8. doi: 10.1097/OPX.0b013e3181c914ed.

Molecular mechanisms of keratinizing ocular surface disease.

Author information

  • 1Department of Anatomy, Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA 94143-0412, USA. nancy.mcnamara@ucsf.edu

Abstract

A devastating consequence of autoimmune-mediated, aqueous tear deficiency is pathological keratinization of the ocular surface. It is setoff by an aberrant immune response that promotes a program of altered mucosal epithelial cell differentiation. The management of keratinizing ocular surface disease is challenging. Topical therapies are largely inadequate for acute exacerbations, and progressive disease often requires systemic immunosuppression. A combination of translational and basic science research is necessary to understand the link between aberrant immunity and pathological keratinization. I review recent research and future directions aimed to develop targeted therapies that control or prevent ocular surface keratinization.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk